1239 related articles for article (PubMed ID: 34717829)
1. Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
Sonabend R; Whittles LK; Imai N; Perez-Guzman PN; Knock ES; Rawson T; Gaythorpe KAM; Djaafara BA; Hinsley W; FitzJohn RG; Lees JA; Kanapram DT; Volz EM; Ghani AC; Ferguson NM; Baguelin M; Cori A
Lancet; 2021 Nov; 398(10313):1825-1835. PubMed ID: 34717829
[TBL] [Abstract][Full Text] [Related]
2. Quantifying the effect of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study.
Imai N; Rawson T; Knock ES; Sonabend R; Elmaci Y; Perez-Guzman PN; Whittles LK; Kanapram DT; Gaythorpe KAM; Hinsley W; Djaafara BA; Wang H; Fraser K; FitzJohn RG; Hogan AB; Doohan P; Ghani AC; Ferguson NM; Baguelin M; Cori A
Lancet Public Health; 2023 Mar; 8(3):e174-e183. PubMed ID: 36774945
[TBL] [Abstract][Full Text] [Related]
3. Association of tiered restrictions and a second lockdown with COVID-19 deaths and hospital admissions in England: a modelling study.
Davies NG; Barnard RC; Jarvis CI; Russell TW; Semple MG; Jit M; Edmunds WJ; ;
Lancet Infect Dis; 2021 Apr; 21(4):482-492. PubMed ID: 33357518
[TBL] [Abstract][Full Text] [Related]
4. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study.
Moore S; Hill EM; Tildesley MJ; Dyson L; Keeling MJ
Lancet Infect Dis; 2021 Jun; 21(6):793-802. PubMed ID: 33743847
[TBL] [Abstract][Full Text] [Related]
5. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries.
Li Y; Campbell H; Kulkarni D; Harpur A; Nundy M; Wang X; Nair H;
Lancet Infect Dis; 2021 Feb; 21(2):193-202. PubMed ID: 33729915
[TBL] [Abstract][Full Text] [Related]
6. Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality.
Patel MD; Rosenstrom E; Ivy JS; Mayorga ME; Keskinocak P; Boyce RM; Hassmiller Lich K; Smith RL; Johnson KT; Delamater PL; Swann JL
JAMA Netw Open; 2021 Jun; 4(6):e2110782. PubMed ID: 34061203
[TBL] [Abstract][Full Text] [Related]
7. Mathematical modelling of vaccination rollout and NPIs lifting on COVID-19 transmission with VOC: a case study in Toronto, Canada.
Aruffo E; Yuan P; Tan Y; Gatov E; Moyles I; Bélair J; Watmough J; Collier S; Arino J; Zhu H
BMC Public Health; 2022 Jul; 22(1):1349. PubMed ID: 35841012
[TBL] [Abstract][Full Text] [Related]
8. The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.
Sandmann FG; Davies NG; Vassall A; Edmunds WJ; Jit M;
Lancet Infect Dis; 2021 Jul; 21(7):962-974. PubMed ID: 33743846
[TBL] [Abstract][Full Text] [Related]
9. Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis.
Milne GJ; Carrivick J; Whyatt D
BMC Med; 2022 Feb; 20(1):80. PubMed ID: 35177062
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
Yang W; Shaman J
medRxiv; 2021 Nov; ():. PubMed ID: 34845460
[TBL] [Abstract][Full Text] [Related]
11. Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts.
Tran TN; Wikle NB; Albert E; Inam H; Strong E; Brinda K; Leighow SM; Yang F; Hossain S; Pritchard JR; Chan P; Hanage WP; Hanks EM; Boni MF
BMC Med; 2021 Jul; 19(1):162. PubMed ID: 34253200
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
Nyberg T; Ferguson NM; Nash SG; Webster HH; Flaxman S; Andrews N; Hinsley W; Bernal JL; Kall M; Bhatt S; Blomquist P; Zaidi A; Volz E; Aziz NA; Harman K; Funk S; Abbott S; ; Hope R; Charlett A; Chand M; Ghani AC; Seaman SR; Dabrera G; De Angelis D; Presanis AM; Thelwall S
Lancet; 2022 Apr; 399(10332):1303-1312. PubMed ID: 35305296
[TBL] [Abstract][Full Text] [Related]
13. Growth, reproduction numbers and factors affecting the spread of SARS-CoV-2 novel variants of concern in the UK from October 2020 to July 2021: a modelling analysis.
Ward T; Glaser A; Johnsen A; Xu F; Hall I; Pellis L
BMJ Open; 2021 Nov; 11(11):e056636. PubMed ID: 34819293
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 among people experiencing homelessness in England: a modelling study.
Lewer D; Braithwaite I; Bullock M; Eyre MT; White PJ; Aldridge RW; Story A; Hayward AC
Lancet Respir Med; 2020 Dec; 8(12):1181-1191. PubMed ID: 32979308
[TBL] [Abstract][Full Text] [Related]
15. Voluntary risk mitigation behaviour can reduce impact of SARS-CoV-2: a real-time modelling study of the January 2022 Omicron wave in England.
Brooks-Pollock E; Northstone K; Pellis L; Scarabel F; Thomas A; Nixon E; Matthews DA; Bowyer V; Garcia MP; Steves CJ; Timpson NJ; Danon L
BMC Med; 2023 Jan; 21(1):25. PubMed ID: 36658548
[TBL] [Abstract][Full Text] [Related]
16. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.
Singanayagam A; Hakki S; Dunning J; Madon KJ; Crone MA; Koycheva A; Derqui-Fernandez N; Barnett JL; Whitfield MG; Varro R; Charlett A; Kundu R; Fenn J; Cutajar J; Quinn V; Conibear E; Barclay W; Freemont PS; Taylor GP; Ahmad S; Zambon M; Ferguson NM; Lalvani A;
Lancet Infect Dis; 2022 Feb; 22(2):183-195. PubMed ID: 34756186
[TBL] [Abstract][Full Text] [Related]
17. Outbreaks of COVID-19 variants in US prisons: a mathematical modelling analysis of vaccination and reopening policies.
Ryckman T; Chin ET; Prince L; Leidner D; Long E; Studdert DM; Salomon JA; Alarid-Escudero F; Andrews JR; Goldhaber-Fiebert JD
Lancet Public Health; 2021 Oct; 6(10):e760-e770. PubMed ID: 34364404
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.
Lopez Bernal J; Andrews N; Gower C; Robertson C; Stowe J; Tessier E; Simmons R; Cottrell S; Roberts R; O'Doherty M; Brown K; Cameron C; Stockton D; McMenamin J; Ramsay M
BMJ; 2021 May; 373():n1088. PubMed ID: 33985964
[TBL] [Abstract][Full Text] [Related]
19. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.
Twohig KA; Nyberg T; Zaidi A; Thelwall S; Sinnathamby MA; Aliabadi S; Seaman SR; Harris RJ; Hope R; Lopez-Bernal J; Gallagher E; Charlett A; De Angelis D; Presanis AM; Dabrera G;
Lancet Infect Dis; 2022 Jan; 22(1):35-42. PubMed ID: 34461056
[TBL] [Abstract][Full Text] [Related]
20. Impact of non-pharmaceutical interventions and vaccination on COVID-19 outbreaks in Nunavut, Canada: a Canadian Immunization Research Network (CIRN) study.
Vilches TN; Abdollahi E; Cipriano LE; Haworth-Brockman M; Keynan Y; Sheffield H; Langley JM; Moghadas SM
BMC Public Health; 2022 May; 22(1):1042. PubMed ID: 35614429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
